Thyroid hormone receptors (TRs) are members of the nuclear receptor superfamily that regulate their target genes for controlling organ development and functional maintenance. Soybean isoflavones, especially genistein and daidzein, modulate various hormone-mediated pathways. However, their effects on TRs have not yet been extensively studied. In this study, the effects of these isoflavones on TR action were evaluated using transient transfection-based reporter gene assays and molecular docking studies. Genistein and daidzein augmented T 3 -liganded TR-mediated transcription in a concentration-dependent manner. In the mammalian 2-hybrid study, these isoflavones augmented the recruitment of steroid receptor coactivator-1 and nuclear corepressor to liganded or unliganded TRs. Using a series of mutant TRs, we also showed that the activation function-2 domain of TRs was responsible for the augmentation by these isoflavones. CV-1 cells had expressed TRa, TRb1, and ERa mRNAs. However, neither the overexpression nor the knocking down of ERa altered the augmentation of TR action by isoflavones, indicating that the effects of isoflavones are exerted through their direct action on TRs. In silico molecular docking studies showed that genistein and daidzein can directly bind to the TR-ligand-binding domain. These findings indicate that the augmentation of the TR-mediated transcription by genistein and daidzein is due to their direct binding to TR-ligand-binding domain to induce the recruitment of steroid receptor coactivator-1. Our study reports a novel mode of action of soybean isoflavones on TR function. The biological effects and the relevance of these isoflavones to human health may be partially attributable to the activation of thyroid hormone signaling.
including the steroid receptor coactivators (SRC)-1, SRC-2, and SRC-3, to activate transcription (Koibuchi and Chin, 2000; Koibuchi, 2008 Koibuchi, , 2013 Wong et al., 2014) .
Isoflavones are a natural class of isoflavonoids. They are produced exclusively by the legume family (Leuner et al., 2013) . They exert various effects at molecular, cellular, and organ levels (We R grzyn et al., 2010) . Among the isoflavones, soybean isoflavones such as genistein and daidzein have been intensively studied. They inhibit proliferation and induce apoptosis in prostate cancer cell lines (LNCaP and PCa cell lines) (Dong et al., 2013) , enhance the retention of bone calcium, down-regulate energy metabolism in human adipose tissues in postmenopausal women (Pawlowski et al., 2015; Velpen et al., 2014) , and improve peroxisome proliferator-activated receptor (PPAR)amediated fatty acid oxidation in mouse liver (Qiu and Chen, 2015) . Such a wide variety of actions indicate that these compounds probably act through several different signaling pathways.
Both genistein and daidzein are well-known phytoestrogens that modulate the action of NRs including the estrogen receptor (ER) by binding to the ligand-binding domain (LBD) of ERa and ERb (Leclercq and Jacquot, 2014) . Soybean isoflavone, especially genistein, showed higher binding affinity to ERb compare with ERa by radioligand solid-phase-binding assay and transactivation assays on human embryonal kidney 293 cells (Kuiper et al., 1998) . Genistein at physiological range (0.5-10 lmol/l) also have been reported induces the reduction of ERb promoter methylation with corresponding increases in ERb expression and induces phosphorylation of ERb (pS105 and pS87), nuclear translocation, and ERb transcriptional activity in prostate cancer cell lines (LNCaP, LAPC-4, and PC-3 cells) (Mahmoud et al., 2013) . In addition, genistein partially antagonizes the activity of the androgen receptor (AR) in a tissue-specific and AR target gene-specific manner in male mice (effective in prostate, testes, and brain, but not in skeletal muscles and lung) (Pihlajamaa et al., 2011) . It may also act as a weak agonist in the brain and prostate tissues of mice (Pihlajamaa et al., 2011) . Genistein also upregulates pregnane X receptor (PXR)-mediated transcription and PXR-mediated CYP3A4 mRNA expression in mouse hepatocytes (Li et al., 2009) . Genistein and daidzein also modulate the protein and mRNA levels of NRs; for example, genistein increases the mRNA levels of ERb in the rat hypothalamus (Patisaul et al., 2002) , decreases the mRNA levels of PPARc during adipogenesis in human primary bone marrow stromal cells (Heim et al., 2004) , and decreases AR protein levels in LNCaP cell lines (Basak et al., 2008) . These findings indicate that genistein and daidzein may exert their actions partly by modulating the action and/or expression of NRs.
The effect of dietary soybean isoflavones on the TH system is rather controversial. Although the goitrogenic effects of soy formula in infants have been well documented, the effects can be reversed by switching the formula to cow milk (Chorazy, 1995) . Although dietary genistein treatment in young adult rat models significantly suppressed the levels of thyroid peroxidase (TPO), the levels of T 3 , T 4 , and TH-stimulating hormone (TSH) were not altered (Chang and Doerge, 2000) . In orchidectomized middle-aged rats, dietary genistein and daidzein weakly suppressed the levels of T 3 and T 4 , and increased both the TSH level and the cellular volume of TSH cells in the pituitary, while decreasing the volume of colloid in the thyroid gland ( So si cJurjevi c, 2010) and suppressing the mRNA levels of thyroglobulin and TPO, which indicate the impairment of TH synthesis. On the other hand, the mRNA levels of spot 14 and type 1 iodothyronine deodinase, which are positively regulated by TH, increased in the liver of the same experimental animal ( So si cJurjevi c et al., 2014). These results indicate that soybean isoflavones may have bimodal effects on the TH system. Although the effect of soybean isoflavones on TR-mediated transcription has not yet been extensively studied, a weak induction of TRamediated transcription by genistein using a conventional reporter assay system has been reported (Hofmann et al., 2009) . However, whether these isoflavones bind to TRs have not been studied.
In addition to the possibility that genistein and daidzein act directly on the TRs, these isoflavones may alter TR action through ERs. Crosstalk between NRs is important for the conversion of external and internal stimuli, which is necessary for eliciting cellular physiological responses (Vasudevan et al., 2001) . The crosstalk and cross-interference between TRs and ERs have been reported in several gene promoters and cell lines (Vasudevan et al., 2001 (Vasudevan et al., 2008 , and is one of the reasons for the binding of TRs and ERs to the common DNA half-site sequence, 5'AGGTCA 3'. These findings indicate that genistein and daidzein may alter the interaction between ERs and TRs, or alter the interaction between TRs and their cofactors due to cofactor squelching by the ERs. However, their effects on the interaction between TRs and ERs are not clear.
In this study, to clarify the effects of the isoflavones on TR activity, we employed reporter gene assays using TRa and TRb expression vectors together with their mutants, in addition to in silico molecular docking. Since a recent study has identified a second TH-binding site located among H9, H10, and H11 of the TR-LBD (Souza et al., 2014) , we also examined the possible binding of the isoflavones to this second binding site. Moreover, we also examined the crosstalk of TRs with ERs by using knockdown and overexpression strategies.
MATERIALS AND METHODS
Chemicals. T 3 , genistein [4', 5, 7-trihydoxyisoflavone or 5, 7-dihydroxy-3-(4-hydoxyphenyl)-4H-1-benzopyran-4-one] ( Figure 1A) , and daidzein [4 0 , 7-dihydroxyisoflavone or 7-hydroxy-3-(4-hydroxyphenyl) chromen-4-one] ( Figure 1B ) were purchased from Sigma (St Louis, Missouri). The purity of all chemicals was above 98%.
Plasmids. The TRa1 and TRb1 expression vectors, luciferase (LUC) reporter constructs, the artificial direct repeat TRE, DR4-TK-LUC (DR4-TRE), and chick lysozyme (F2)-thymidine kinase (TK)-LUC (F2-TRE) have been described in previous studies (Iwasaki et al., 2001; Koibuchi et al., 1999) . The LBD of VP16-TRb1-has been previously described in Miyazaki et al. (2004) . Gal4-blank, the expression vector for the Gal4-DNA-binding domain (DBD)-fused SRC-1-NR-binding domain (NBD)-1 (amino acids 595-780), Gal4-N-CoR-nuclear receptor-interacting domain (RID) (amino acids 1579-2454) and Gal4-SMRT-RID (amino acids 1669-2507) have been described in a previous study . The mutated TR plasmid DN.hTRb1 that has an AF-1-binding domain with a truncated N-terminal; E457A, a fulllength hTRb1 containing a point mutation (glutamate to alanine) in codon 457 at the AF-2 domain; and DN.E457A, that has both the truncated N-terminal and the E457A mutation have been described in a previous study (Iwasaki et al., 2006) .
Clonal cell culture. Monkey kidney fibroblast-derived clonal cells, CV-1, were maintained in Dulbecco's modified Eagle's medium supplemented with 10% fetal bovine serum and antibiotics (100 U/ml penicillin, and 100 mg/ml streptomycin), at 37 C with 5% CO 2 . The serum was stripped of hormones by constantly mixing with 5% (w/v) AGX1-8 resin (Bio-Rad, Hercules, California) and powdered charcoal, prior to ultrafiltration (Iwasaki et al., 2002) .
Transient transfection-based reporter gene assay. Cells were plated at a density of 1 Â 10 4 /0.1 ml in 96-well plates and incubated for 24 h, followed by transfection of the expression vectors and a reporter plasmid using HilyMax transfection reagents (Dojindo Molecular Technologies, Inc.), according to the protocol described in the technical manual. Expression vectors encoding TRa1 or TRb1 (4 ng) were cotransfected with the reporter plasmid (F2-TRE-LUC) (40 ng) into CV-1 cells. The internal control was a cytomegalovirus-b-galactosidase plasmid (4 ng). The cells were incubated after 16-18 h of transfection with fresh medium containing indicated concentrations of the ligand (10 À7 M T 3 ) and either of genistein or daidzein for 24 h. The cells were then harvested to measure LUC activity as described in a previous study (Iwasaki et al., 2002) . The total amounts of DNA per well were balanced by adding pcDNA3 plasmids (Invitrogen, San Diego, California). The LUC activity was normalized to b-galactosidase activity and represented as relative LUC activity. All transfection experiments were carried out in triplicate. The data are represented as the mean 6 SEM of one representative experiment performed in triplicate.
RNA interference and cell transfection. Short interfering RNAs (siRNAs) for ERa (ESR1) and control RNAs were purchased from Thermo Fisher Scientific (Massachusetts). The siRNAs were transfected into CV-1 cells using lipofectamine RNAiMAX reagent (Thermo Fisher), according to the manufacturer's protocol. Briefly, the siRNA-lipid complexes (25 nM control siRNA (scrambled RNA) or 25 nM ESR1 siRNA) were added to 96-well plates, and incubated for 20 min. CV-1 cells at a density of 1 Â 10 4 cells/well were seeded in 96-well plates using media free from phenol red and antibiotics.
After 16-24 h, the cells were subjected to analyses with reporter gene assays. The efficacy of the siRNA knockdown of ERa was verified by quantitative real-time PCR (qRT-PCR).
RNA isolation and quantitative real-time RT-PCR. The total RNA was isolated using QIAzol Lysis reagent (QIAGEN) and reverse transcribed using ReverTra Ace qPCR RT master mix (TOYOBO BioTechnology, Japan) based on the instruction manual provided by the supplier. RT-PCR was performed using THUNDERBIRD SYBR qPCR mix (TOYOBO Bio-Technology, Japan) as described in the instruction manual and the StepOne RT-PCR System (Applied Biosystems). The list of primers used in this study is listed in Table 1 . The RT-PCR protocol for all genes involved denaturation at 95 C for 20 s, followed by amplification at 95 C for 3 s and at 60 C for 30 s (40 cycles). All experiments were repeated 3 times, using independent RNA preparations to confirm the consistency of the results. The mRNA levels were normalized by the mRNA level of GAPDH.
In silico ligand-receptor-binding calculations. All in silico calculations were performed using an Asus N43s notebook with an Intel Core i3 -2310 M dual-core processor, 3 M cache, 2.10 GHz CPU, 1333 MHz DDR3 SDRAM, and 8 GHz RAM, running on a Windows 10 professional operating system. The molecular structure of genistein (PubChem CID 5280961), daidzein (PubChem CID 5281708), and T 3 (PubChem CID 5920) were downloaded from PubChem (https://pubchem.ncbi.nlm.nih.gov/; last accessed May 17, 2017) in the structure data file format. substructures (bound molecules or ligand molecules) were removed from the coordinate file before docking. The unliganded TR-LBD was used for the individual dockings of T 3 , genistein, and daidzein. Polar hydrogen atoms were added to the 3D structure of the TR-LBD and the input file was generated in the PDBQT format, which contained the structure of the TR-LBD, using AutoDockTools of MGLTools (http://autodock.scripps.edu/ resources/adt; last accessed May 17, 2017). The coordinates for docking were determined through a grid box using the PyRxPython Prescription 0.8 Virtual Screening software for Computer-Aided Drug Design (http://pyrx.sourceforge.net/; last accessed May 17, 2017), using AutoDock 4 and AutoDock Vina as docking software (Trott and Olson, 2010) . A blind docking strategy was utilized in order to include the entire possible binding site for ligands. For more reliable results, refinement docking experiments with repetitions of 30 runs were performed with complexes which had high affinity scores (lower than À9 kcal/ mol). LigPlot þ v.1.4 (http://www.ebi.ac.uk/thornton-srv/software/LigPlus/; last accessed May 17, 2017) was used to determine the interactions between the TR-LBDs and the ligands in complexes with the best affinity scores. The binding affinity was expressed as the binding free energy (kcal/mol).
Statistical analysis. All the data are expressed as the mean 6 SEM of 3 individual experiments performed in triplicate and analyzed using ANOVA. Post hoc comparisons were made using Bonferroni's test. A p value < .05 was considered to be significant. The AF-2 Domain of TRs Is Essential for the Augmentation of TR-Mediated Transcription by the Isoflavones We further performed transient transfection-based reporter gene assays in CV-1 cells using a series of truncation and/or point mutants of TRb1 to identify the domain of TR responsible for the transcriptional augmentation by isoflavones. The transcription through DN.hTRb1, which is an N-terminus truncated mutant, was augmented by genistein and daidzein, and the transcription levels were similar to the wild type TRb1 (Figure 3 ). On the other hand, the transcriptions through the hTRb1-AF2 (E457A) and DN.hTRb1-AF2 mutants were not augmented by the isoflavones (Figure 3 ). These results indicate that the AF-2 domain is responsible for the transcriptional augmentation by genistein and daidzein.
RESULTS

Genistein and
The Augmentation of TR-Mediated Transcription by Isoflavones Is Not Altered by ERa Overexpression or Knockdown
We measured the mRNA expression levels of TRs and ERs in CV-1 cells prior to the modulations in ER expression. The expression of TRs and ESR1 (ERa) was confirmed, whereas ESR2 (ERb) expression could not be detected (Supplementary Figure  3) . Based on the expression levels of ERs in CV-1 cells, we cotransfected ERa to CV-1 cells to further examine the involvement of ER, especially the effects of ERa overexpression. The overexpression of ERa did not further augment the transcription mediated by TRb ( Figure 4A ) and TRa (Supplementary Figure 4A) in the presence of the isoflavones. These results indicate that ERa may not be involved in isoflavone-induced augmentation of TR-mediated transcription. To further examine whether the effects of genistein and daidzein were indeed induced through ERa, the ERa mRNA was knocked down using RNA interference. The CV-1 cells were transiently transfected with ERa siRNA. The decrease in the expression of ERa mRNA was confirmed by qRT-PCR. The siRNA treatment induced a 98.6% reduction in ERa mRNA levels compared with the control (Supplementary Figure  4B) . After knocking down the ERa mRNA in CV-1 cells, we performed reporter gene assays. The magnitude of TRb transcription induced by 10 À5 M genistein or daidzein ( Figure 4B ) and Figure  4C) did not decrease after ERa knockdown. These results indicated that both genistein and daidzein might directly bind to TRs and augment TR-mediated transcription, although there might be differences in genistein and daidzein action on the interaction of TRs. Taken together with the study of ERa overexpression, the results of this study indicate that ERa is not involved in isoflavone-augmented TR transcription.
TRa-mediated transcription in DR4-TRE (Supplementary
Genistein and Daidzein Can Directly Bind to the First and Second Binding Pockets of TR-LBD
To investigate the binding modes of genistein and daidzein to the TR-LBD, we generated in silico binding models by molecular docking using AutoDocks Vina (Trott and Olson, 2010) . We used several TRa-LBD crystal structures, including 4LNX (crystal structure of TRa bound to T 4 in the second binding site), 4LNW (crystal structure of TRa bound to T 3 in the second binding site), 3JZB (crystal structure of TRa bound to the selective thyromimetic TRIAC (3,3 0 ,5-Triiodothyroacetic acid)), and 3HZF (crystal structure of TRa bou[nd to selective thyromimetic GC-1 in C2 space group). We used the TRa-LBD crystal structure with PDB ID 4LNX and performed molecular docking study with T 3 ( Figure 5A ). We then performed the molecular docking study with genistein and daidzein. Genistein and daidzein could directly bind to the binding pockets of the TRa-LBD (Figs. 5B and 5C and Supplementary Figs . 5B and 5C) with a binding affinity À9.9 and À9.8 kcal/mol, respectively. The molecular docking studies of genistein and daidzein showed that the same amino acid residues in the crystal structure that interacted with T 3 , also interacted with genistein and daidzein, which included residues ile 222, ala 225, ser 277, leu 276, and leu 292 of the first binding site ( Figure 5D ) and arg 375 of the second binding site ( Figure 5E ). In the model obtained by molecular docking, genistein was located at 2.76 Å from ser 277 and 2.90 Å from phe 218 in the first binding site, and had the possibility to form hydrogen bonds. In the second binding site, genistein was located at 3.32 Å from arg 375, 2.49 Å from gln 342, and 2.52 Å from thr 327. The residues shown in red circles in Figures 5D and 5E the amino acid residues of TR-LBD that are common to T 3 and genistein binding. We also performed in silico calculations for daidzein (Supplementary Figure 5) and determined the binding affinity of T 3 , genistein, and daidzein with other crystal structures of the TRa-LBD (PDB IDs 4LNW, 3JZB, and 3HZF) in both the binding pockets (Table 2) .
DISCUSSION
In this study, we examined the effect of soybean isoflavones (genistein and daidzein) on TR-mediated transcription. We found that these isoflavones augmented the transcription mediated by liganded TRs in a concentration-dependent manner. ERs may not be involved in such augmentation as shown by the ER overexpression and siRNA studies. Using in silico analyses, we also found that these isoflavones may directly interact with the TR-LBD. These results describe a novel mechanism of action of genistein and daidzein on the augmentation of TR-mediated transcription by the direct binding of the isoflavones to TRs and TH-mediated signal transduction. Soybean isoflavones activate various NR-mediated transcriptions including those of ERs (Leclercq and Jacquot, 2014; Patisaul et al., 2002) , and PXR (Li et al., 2009 ). Dietary soy protein isolates have been reported to upregulate hepatic TRb1 expression levels in rats (Xiao et al., 2004) . LUC reporter gene assay with ERs in human hepatoma cells (HepG2 cells) showed that both genistein and daidzein were complete agonist at both ER, genistein being more potent than daidzein. In addition, both genistein and daidzein were more potent to ERb compare with ERa (Casanova et al., 1999) . However, their effects on TR-mediated transcription have not been extensively studied. This study clearly shows that both genistein and daidzein augmented the transcription mediated by liganded TRs in a concentrationdependent manner. In contrast, in the absence of T 3 , only high doses of genistein and daidzein could weakly augment the transcription mediated by TRb and TRa. This weak activation appears to be in agreement with a previous study which reported a weak transactivation of TR activity by genistein in the absence of T 3 (Hofmann et al., 2009) . In that study, genistein at a concentration of 10 À6 M induced a 2.3-folds increase in the level of transcription in comparison to the basal level (without T 3 ). Although the 2.3-fold increase with respect to the basal level seemed significant, the level of transcription was still rather low, because the basal transcription level in the absence of a ligand is repressed by interactions with corepressors. In this study, the TR-mediated transcription through F2-TRE with standard soy or soy-almond bread (Ahn-jarvis et al., 2015) , and reached 1-10 mM at 4-7 h after the intake of 50 g of kinako (roasted soybean powder) in human subjects (Hosoda et al., 2008) . In this study, TR-mediated transcription was augmented by genistein and daidzein at doses comparable to those in the aforementioned studies (Figs. 1C and 1D ). Previously, we had performed the MTS cell proliferation assay and showed that both genistein and daidzein concentrations that were used in this study did not affect the viability of CV-1 cells (Supplementary Figure 6) . Unless large amounts are administered, their adverse effects cannot be reported. Since soybeans have been consumed throughout human evolution, isoflavones can be effectively metabolized in humans. The half-lives of plasma genistein and daidzein are 8.36 and 5.79 h, respectively (Watanabe et al., 1998) . Thus, the endocrine-modulating action of the soy isoflavones under normal physiological conditions may be beneficial to our health, although further studies are required to confirm this, especially at acute and massive doses. Such a possibility indicates that isoflavones can be used as a supplement for patients with low T 3 syndromes or to relieve hypothyroidism-induced clinical symptoms. The interaction of TRs with the cofactor SRC-1 induced by T 3 , was augmented by genistein and daidzein. However, only high doses of genistein and daidzein could augment the interactions with TR-N-CoR and TR-SMRT. Studies have also reported the augmentations in the interactions of SRC-1 with other NRs by genistein and daidzein. According to previous studies, genistein augmented the interaction of SRC-1 with ERa (Schwartz et al., 1998) , and ERb (Mueller et al., 2004) . Additionally, modulations in N-CoR action by genistein have been reported. Genistein upregulated the expression of N-CoR protein and reversed promyelocytic leukemia (PML)-retinoic acid receptor (RAR)-induced misfolding of N-CoR protein possibly by inhibiting the selective phosphorylation-dependent binding of N-CoR to PML-RAR in acute PML cells (Ng et al., 2007) . In this study, we showed that both genistein and daidzein augmented the interactions of a TR-coactivator (TR-SRC-1) and TR-corepressors (TR-N-CoR and TR-SMRT) at high doses (Figure 2) . Moreover, using a series of truncated and/or point mutants of TRb1, we found that the TR-LBD region and especially its AF-2 domain, is responsible for the augmentation in TR-mediated transcription induced by genistein and daidzein (Figure 3) . The augmentation was observed with the N-terminus-truncated mutant, but not with AF-2 mutants. These results indicate that the TR-mediated transcription augmented by genistein and daidzein might have altered the conformation of AF-2, which modulated the binding of TRs to cofactors. Together with the results of mammalian 2 hybrid assays, it is likely that the isoflavone-induced increase in the interactions of SRC-1 to the AF-2 domain modified the chromatin structure which augmented transcription. On the other hand, although these isoflavones also augmented the recruitment of corepressors, transcription was not further repressed. The reason for this discrepancy cannot be clarified. Further studies are necessary for clarifying the mechanisms of increase in coactivator/corepressor recruitment by isoflavones.
Soybean isoflavones are well-known phytoestrogens that act through ERs (Mueller et al., 2004; Patisaul et al., 2002) . Since a previous study reported the possibility of crosstalk between TRs and ERs (Vasudevan et al., 2001) , we speculated whether the effect of isoflavones on TRs is a result of the indirect binding of isoflavones to ERs. To further investigate the crosstalk between ERs and TRs, we separately overexpressed and knocked-down ERa, and observed that both genistein and daidzein augmented TR-mediated transcription in both the states of ERa overexpression and knockdown. These results indicate that ERa is not involved in the augmentations of both TR-mediated transcription and TR-cofactor interactions, induced by genistein and daidzein. We also confirmed that the transactivation mediated by TRs in the presence of T 3 was increased by ERa knockdown ( Figure 4B and Supplementary Figure 4C) . However, genistein and daidzein might acts through both of ERs and TRs in the in vivo study. Transcriptomic analysis showed that genistein regulated some ER-responsive genes in the cell proliferation, adhesion, motility and inflammatory response proses (Gong et al., 2014) . Some of these genes were also included in TR responsive gene. The increase of body weight in ovariectomized rats was reduced by co-administration of genistein and ERbspecific agonist 8b-VE2, and suggesting that the activation of ERb may modulate ERa-mediated physiological effects in vivo (Hertrampf et al., 2009) . A previous study showed that there is a cross-interference (squelching) between TRs and ERs with regard to the binding of coactivators, including SRC-1 (Lopez et al., 1999) . In fact, we confirmed the expression of SRC-1 mRNA in CV-1 cells (Supplementary Figure 3) . These reasons explain the increased transactivation induced by ER knockdown. Nevertheless, the action of isoflavones on TRs may be directly induced and exerted through the TH signal transduction pathway since THs regulate various metabolic pathways.
In this study, we also showed a possibility using in silico docking studies that these isoflavones may directly bind to the TR-LBD. Like other NRs, the TR LBDs has a core-binding site for T 3 where the ligand is buried. The binding of THs change the conformation of TRs (Souza et al., 2014; Moras et al., 2015) . The binding of the isoflavones to the TR-LBD may also induce conformational changes in the structure of TRs by inducing the recruitment of cofactors. In addition, a recent study identified a new hormone-binding site referred to as the second binding site, on the surface of the TR-LBD (Souza et al., 2014) . We have shown that isoflavones can also bind to this second binding site, although the affinity is lower than the affinity with the first binding site. Importantly, the augmentations induced by the isoflavones were mainly observed in the presence of T 3, indicating that both T 3 and the isoflavones should be simultaneously bound in the TR complex to cause augmentations. Although the exact binding mode of T 3 and the isoflavones could not be verified in this study, several possibilities have been considered, which need to be investigated in order to identify the roles and interaction between the first and second binding sites in TRmediated transactivation. Moreover, we also need to examine whether the binding mode of TRs to the TRE may be changed by isoflavone-liganded TRs, because TRs can form homodimers and TR-RXR heterodimers for binding to TRE.
In summary, isoflavones such as genistein and daidzein augment TR-mediated transcription at least in part by increasing the recruitment of SRC-1. Such augmentation may be caused by the direct binding of genistein and daidzein to the TR-LBD. However, further studies are required to clarify the mechanism; the results of this study provide a new insight into the understanding of the actions of genistein and daidzein on TRs.
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